View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
June 15, 2020

ams and Senova partner to develop rapid antibody test for Covid-19

High-performance sensor solutions supplier ams and in vitro diagnostic medical devices manufacturer Senova have partnered to develop a rapid antibody test for Covid-19.

High-performance sensor solutions supplier ams and in vitro diagnostic medical devices manufacturer Senova have partnered to develop a rapid antibody test for Covid-19.

Free Report
img

Navigate your business through the ‘new normal’

COVID-19 continues to dominate headlines the world over. It has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities.  Faced with an explosion of conflicting information on how to plan and implement successful recovery strategies, decision-makers are in dire need of a single, reliable source of intelligence.   GlobalData’s COVID-19 Executive Briefing gives you access to unparalleled data and insights to successfully navigate the uncertain road to recovery across the world’s largest industries. Understand every aspect of this disruptive theme by delving into: 
  •  COVID-19 infection update, with statistics on the spread, testing by country, as well as the latest data on vaccines and therapeutic developments 
  • Economic impact overview, covering stock market indices, GDP, unemployment rates, policy responses & GlobalData’s economic recovery scorecards 
  • Sector developments, with access to sector insight summaries, cross-sector indices and the leaders and laggards in each industry vertical 
Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today. 
by GlobalData
Enter your details here to receive your free Report.

A specially designed sensor module based on the ams AS7341L spectral sensor solution is said to enable spectrally resolved readout of lateral flow immune assays.

The ams spectral sensor technology was successfully tested in combination with Senova´s commercially available serological IgG/M Covid-19 assay.

Based on this, the companies are entering a partnership to combine the read-out technology of ams with the lateral flow-test capabilities of Senova.

Both companies have agreed on developing a disposable electronic lateral flow test towards testing for immunity against the SARS-CoV-2 virus based on antibody detection.

ams Advanced Optical Sensors Division EVP commented Jennifer Zhao said: “ams’ innovation through miniaturised and cost-effective spectral sensor technology is more valuable than ever for healthcare applications.

“Enabling rapid test devices to detect colourimetric and fluorescence information through a tiny, yet powerful, optical sensor supports wide-spread testing for viruses and antibodies at disposable cost levels. With this technology, we hope to contribute to the fight against the pandemic the world is facing right now.”

In addition, ams will partner with healthcare manufacturing solutions provider Jabil Healthcare to integrate its sensor technology into a high-volume turnkey module, featuring a Bluetooth connection. The partnership will enable the company to attain manufacturing scale in an accelerated timeframe.

ams, Senova and Jabil are anticipated to roll out the CE medical-certified, disposable test kits by September.

Senova CEO Hans Hermann Söffing said: “This collaborative project is a great opportunity to provide a new generation of point-of-care tests, which combine fundamental improvements in accuracy and superior handling at the same time.

“A digital Covid-19 antibody test kit will be the next important element to support healthcare providers worldwide in the current situation.”

Related Companies

Free Report
img

Navigate your business through the ‘new normal’

COVID-19 continues to dominate headlines the world over. It has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities.  Faced with an explosion of conflicting information on how to plan and implement successful recovery strategies, decision-makers are in dire need of a single, reliable source of intelligence.   GlobalData’s COVID-19 Executive Briefing gives you access to unparalleled data and insights to successfully navigate the uncertain road to recovery across the world’s largest industries. Understand every aspect of this disruptive theme by delving into: 
  •  COVID-19 infection update, with statistics on the spread, testing by country, as well as the latest data on vaccines and therapeutic developments 
  • Economic impact overview, covering stock market indices, GDP, unemployment rates, policy responses & GlobalData’s economic recovery scorecards 
  • Sector developments, with access to sector insight summaries, cross-sector indices and the leaders and laggards in each industry vertical 
Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today. 
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU